Carcinoid Syndrome

• FDA label_change · 2018-08-27
  FDA Approved: OCTREOTIDE ACETATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  The FDA approved a supplemental application for Octreotide Acetate submitted by Hikma Pharmaceuticals USA Inc., updating the product labelin…

• FDA label_change · 2011-09-30
  FDA Approved: SANDOSTATIN LAR DEPOT — Supplemental Application (Novartis Pharmaceuticals Corporation)

  FDA supplemental application for Sandostatin LAR Depot (octreotide acetate) submitted by Novartis Pharmaceuticals Corporation, involving cha…